SCOTUS ruling on mifepristone could have lasting impact on FDA regulation: Experts

SCOTUS ruling on abortion pill mifepristone could have lasting impact on FDA regulation: Expertsto not restrict nationwide access to the abortion pill mifepristone, they warn access to medication abortion remains at risk -- as does the very foundation of the Food and Drug Administration's regulation of all medications.

"The idea of limiting access to mifepristone will just further exacerbate disparities that we're already seeing in terms of reproductive health care," said Dr. Reshma Ramachandran, a family physician, health services researcher and assistant professor at Yale University School of Medicine. The American Civil Liberties Union also warned that the ruling was not the end of challenges to the abortion pill.

The Supreme Court has not yet issued a decision on another case on its docket this term that could have a wider impact on lifesaving emergency abortion care across the country, including states that ban the procedure. The other case -- Moyle v. U.S. -- centers on Idaho's total abortion ban, which prohibits the procedure at all stages of pregnancy, with exceptions to save the life of a pregnant woman or in cases of rape or incest.

"A number of us have been watching these court cases, and have been worried about the idea that judges -- without clinical or technical expertise -- would be weighing in on the scientific decisions that are being made by the FDA," said Ramachandran, who is also the chair of Doctors for America's task force on FDA policy."It's a very lengthy process to be able to get drug approval.

Had the court ruled differently, there was wide concern that it would set the dangerous precedent that judges -- who may not have the requisite expertise -- would limit patient access to products, Ramachandran said.

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

SCOTUS ruling on mifepristone could have lasting impact on FDA regulation: ExpertsThe U.S. Supreme Court refused to restrict nationwide access to mifepristone.
Source: 6abc - 🏆 250. / 63 Read more »

SCOTUS ruling on mifepristone could have lasting impact on FDA regulation: ExpertsThe U.S. Supreme Court refused to restrict nationwide access to mifepristone.
Source: ABC7NY - 🏆 592. / 51 Read more »

SCOTUS rejects lawsuit over FDA’s approval of the abortion pillIn a unanimous decision, the court ruled the Alliance for Hippocratic Medicine lacked legal standing to challenge the FDA.
Source: verge - 🏆 94. / 67 Read more »

Abortion Pill Lawsuit: Even SCOTUS Justice Brett Kavanaugh Tears Case ApartThe conservative-leaning Supreme Court has slapped down a challenge to the availability of mifepristone, a widely-used abortion pill.
Source: thedailybeast - 🏆 307. / 63 Read more »

Biden says the 'fight for reproductive freedom continues' despite SCOTUS mifepristone rulingBiden vowed that he and Vice President Harris will fight for abortion rights.
Source: ABC - 🏆 471. / 51 Read more »